Kenji Nakano

5.1k total citations
179 papers, 3.9k citations indexed

About

Kenji Nakano is a scholar working on Oncology, Pulmonary and Respiratory Medicine and Surgery. According to data from OpenAlex, Kenji Nakano has authored 179 papers receiving a total of 3.9k indexed citations (citations by other indexed papers that have themselves been cited), including 70 papers in Oncology, 50 papers in Pulmonary and Respiratory Medicine and 43 papers in Surgery. Recurrent topics in Kenji Nakano's work include Sarcoma Diagnosis and Treatment (22 papers), Head and Neck Cancer Studies (18 papers) and Lymphoma Diagnosis and Treatment (18 papers). Kenji Nakano is often cited by papers focused on Sarcoma Diagnosis and Treatment (22 papers), Head and Neck Cancer Studies (18 papers) and Lymphoma Diagnosis and Treatment (18 papers). Kenji Nakano collaborates with scholars based in Japan, United States and South Korea. Kenji Nakano's co-authors include Masao Tanaka, Shunji Takahashi, Kazuo Chijiiwa, Koji Yamaguchi, Mitsuo Katano, Hideya Onishi, Takao Ohtsuka, Jiro Ohuchida, Takashi Morisaki and Joseph C. Glorioso and has published in prestigious journals such as Circulation, Journal of Clinical Oncology and SHILAP Revista de lepidopterología.

In The Last Decade

Kenji Nakano

171 papers receiving 3.7k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Kenji Nakano Japan 35 1.6k 1.2k 889 749 624 179 3.9k
R. Linke Germany 33 1.4k 0.9× 1.9k 1.6× 756 0.9× 1.5k 2.0× 664 1.1× 152 5.2k
Peter S. Amenta United States 34 638 0.4× 1.5k 1.3× 982 1.1× 631 0.8× 539 0.9× 115 5.0k
Martin K. Selig United States 32 1.2k 0.8× 2.6k 2.2× 1.0k 1.2× 541 0.7× 944 1.5× 79 5.5k
Jeong Hoon Kim South Korea 35 583 0.4× 1.3k 1.1× 899 1.0× 716 1.0× 818 1.3× 193 4.5k
Gaetano Magro Italy 39 678 0.4× 1.5k 1.3× 978 1.1× 1.0k 1.3× 428 0.7× 300 5.7k
Riko Kitazawa Japan 39 1.5k 0.9× 2.7k 2.3× 578 0.7× 407 0.5× 811 1.3× 230 5.6k
Toshimitsu Suzuki Japan 36 667 0.4× 1.7k 1.4× 628 0.7× 659 0.9× 421 0.7× 201 4.3k
Christodoulos Xinaris Italy 24 1.1k 0.7× 2.4k 2.0× 883 1.0× 383 0.5× 217 0.3× 54 4.3k
Susan Müller United States 39 1.3k 0.8× 1.1k 0.9× 1.2k 1.3× 554 0.7× 378 0.6× 117 4.5k
Masato Fujii Japan 32 834 0.5× 818 0.7× 667 0.8× 677 0.9× 633 1.0× 216 3.1k

Countries citing papers authored by Kenji Nakano

Since Specialization
Citations

This map shows the geographic impact of Kenji Nakano's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Kenji Nakano with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Kenji Nakano more than expected).

Fields of papers citing papers by Kenji Nakano

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Kenji Nakano. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Kenji Nakano. The network helps show where Kenji Nakano may publish in the future.

Co-authorship network of co-authors of Kenji Nakano

This figure shows the co-authorship network connecting the top 25 collaborators of Kenji Nakano. A scholar is included among the top collaborators of Kenji Nakano based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Kenji Nakano. Kenji Nakano is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Nakano, Kenji, Akira Kawashima, Takato Nakamoto, et al.. (2025). Early diagnosis of progressive multifocal leukoencephalopathy in untreated HIV infection via ultrasensitive PCR testing for JC virus: A case report. IDCases. 40. e02229–e02229. 2 indexed citations
2.
Fukuda, Naoki, Kazuhisa Toda, Ryosuke Oki, et al.. (2024). Clinical impact of proteinuria on renal function and treatment outcomes in patients with radioiodine-refractory thyroid cancer treated with lenvatinib. Endocrine Journal. 71(4). 363–371. 1 indexed citations
3.
Nakano, Kenji. (2023). Inflammatory myofibroblastic tumors: recent progress and future of targeted therapy. Japanese Journal of Clinical Oncology. 53(10). 885–892. 11 indexed citations
4.
Nakano, Kenji. (2022). Challenges of Systemic Therapy Investigations for Bone Sarcomas. International Journal of Molecular Sciences. 23(7). 3540–3540. 17 indexed citations
5.
Ohmoto, Akihiro, Yu Fujiwara, Nobuyuki Horita, Kenji Nakano, & Shunji Takahashi. (2022). Platinum-doublet chemotherapy for advanced gastroenteropancreatic neuroendocrine carcinoma: a systematic review and meta-analysis. Discover Oncology. 13(1). 3 indexed citations
6.
Sato, Yasuyoshi, Kenji Nakano, Xiaofei Wang, et al.. (2021). Pre-Treatment Neutrophil-to-Lymphocyte Ratio (NLR) as a Predictive Marker of Pazopanib Treatment for Soft-Tissue Sarcoma. Cancers. 13(24). 6266–6266. 10 indexed citations
7.
Nakano, Kenji. (2021). Progress of molecular targeted therapy for head and neck cancer in clinical aspects. Molecular Biomedicine. 2(1). 15–15. 4 indexed citations
8.
Takahashi, Shunji, Yutaka Fujiwara, Kenji Nakano, et al.. (2021). Safety and pharmacokinetics of milademetan, a MDM2 inhibitor, in Japanese patients with solid tumors: A phase I study. Cancer Science. 112(6). 2361–2370. 43 indexed citations
9.
Sato, Yukiko, Naoki Fukuda, Tetsuya Urasaki, et al.. (2020). Efficacy of Nivolumab for Head and Neck Cancer Patients with Primary Sites and Histological Subtypes Excluded from the CheckMate-141 Trial. SHILAP Revista de lepidopterología. 1 indexed citations
10.
Nakano, Kenji, Masatoshi Nishizawa, Naoki Fukuda, et al.. (2020). Mycophenolate mofetil as a successful treatment of corticosteroid-resistant immune checkpoint inhibitor-induced hepatitis. Oxford Medical Case Reports. 2020(4-5). omaa027–omaa027. 16 indexed citations
11.
Nakano, Kenji & Shunji Takahashi. (2020). Precision Medicine in Soft Tissue Sarcoma Treatment. Cancers. 12(1). 221–221. 19 indexed citations
12.
Nakano, Kenji, Keiko Hayakawa, Yuki Funauchi, et al.. (2020). Differences in the efficacy and safety of eribulin in patients with soft tissue sarcoma by histological subtype and treatment line. Molecular and Clinical Oncology. 14(1). 13–13. 6 indexed citations
13.
Nakano, Kenji, Yuki Funauchi, Keiko Hayakawa, et al.. (2019). Relative Dose Intensity of Induction-Phase Pazopanib Treatment of Soft Tissue Sarcoma: Its Relationship with Prognoses of Pazopanib Responders. Journal of Clinical Medicine. 8(1). 60–60. 11 indexed citations
14.
Nakano, Kenji, Keisuke Ae, Seiichi Matsumoto, & Shunji Takahashi. (2019). The VAC regimen for adult rhabdomyosarcoma: Differences between adolescent/young adult and older patients. Asia-Pacific Journal of Clinical Oncology. 16(2). e47–e52. 3 indexed citations
15.
Nakano, Kenji, Akira Seto, Tōru Sasaki, et al.. (2019). Incidence and risk factors of interstitial lung disease of patients with head and neck cancer treated with cetuximab. Head & Neck. 41(8). 2574–2580. 12 indexed citations
16.
Nakano, Kenji & Shunji Takahashi. (2018). Translocation-Related Sarcomas. International Journal of Molecular Sciences. 19(12). 3784–3784. 36 indexed citations
17.
Nakano, Kenji & Shunji Takahashi. (2018). Current Molecular Targeted Therapies for Bone and Soft Tissue Sarcomas. International Journal of Molecular Sciences. 19(3). 739–739. 36 indexed citations
18.
Nakano, Kenji, Takeshi Yuasa, Nao Nishimura, et al.. (2012). Feasibility and Efficacy of Combined Cisplatin and Irinotecan Chemotherapy for Poorly Differentiated Neuroendocrine Carcinomas. Japanese Journal of Clinical Oncology. 42(8). 697–703. 34 indexed citations
19.
Nakano, Kenji, et al.. (2008). メシル酸イマチニブ(STI571)の局部送達-生体外統合化ナノ粒子による静脈新生内膜肥厚の抑制. Circulation. 118(14). 65–98.
20.
Yasui, Y., Kenji Nakano, & Noboru Mizuno. (1992). Descending projections from the subparafascicular thalamic nucleus to the lower brain stem in the rat. Experimental Brain Research. 90(3). 508–18. 33 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by R. Linke Breakdown of academic impact, for papers by Peter S. Amenta Breakdown of academic impact, for papers by Martin K. Selig Breakdown of academic impact, for papers by Jeong Hoon Kim Breakdown of academic impact, for papers by Gaetano Magro Breakdown of academic impact, for papers by Riko Kitazawa Breakdown of academic impact, for papers by Toshimitsu Suzuki Breakdown of academic impact, for papers by Christodoulos Xinaris Breakdown of academic impact, for papers by Susan Müller Breakdown of academic impact, for papers by Masato Fujii
Rankless by CCL
2026